Trajenta
Trajenta, a medicine used in the treatment of Type 2 diabetes, is based on the active substance linagliptin. It falls under a class of medications better known as DPP-4 inhibitors. Clinically proven results show that Trajenta improves glycaemic control in adults.
Images for illustrative purposes only
Trajenta
Trajenta, a medicine used in the treatment of Type 2 diabetes, is based on the active substance linagliptin. It falls under a class of medications better known as DPP-4 inhibitors. Clinically proven results show that Trajenta improves glycaemic control in adults.